Markets Today: Oil, Pixies, and Slightly Worried Accountants

by

The Grand Index of Generally Accepted Value1, known to some as the S&P 500, dipped a fractional amount – 0.37% to 6,556.37. The Nasal Composite2, a collection of enterprises dealing in things that glow and make noises, fared worse, tumbling 0.84% to 21,761.89. The Dow Jones Industrial Average, stubbornly clinging to the notion that industry still exists, merely slipped 0.18% to 46,124.06, after a day of trading driven by the price of refined dinosaur juice – or, as the modern alchemists call it, oil.

Market Movers and Shakers

Oracle, a purveyor of prophecies…err, software, shed almost 5%, continuing a retreat from its earlier, inflated valuation. One begins to suspect the oracles were simply very good at marketing. Similar establishments, such as ServiceNow and Salesforce, also experienced a downward adjustment in perceived worth. The arrival of new, shiny, artificial intelligences from Amazon.com—those little clockwork minds—seems to have unsettled the sector. Even Microsoft, a company that once cornered the market on digital scrolls, lost a bit of its lustre, dipping almost 3%. It appears even the most established empires can be caught unawares by a clever new innovation…or a particularly persuasive sales goblin.

In the realm of biological enhancements, Immunic saw a near 7% surge following a favourable assessment from Guggenheim. One can only assume Guggenheim’s soothsayers saw something promising in Immunic’s potions. Conversely, ImmunityBio suffered a setback due to a stern warning from the regulatory authorities – a cautionary tale about the dangers of overpromising miracle cures, even in the age of advanced alchemy.

What This Means for Those Counting Their Coin

The price of oil, and the ongoing…discussions in the region of the Strait of Hormuz, continue to cast a long shadow over the markets. Brent crude, that essential lubricant of modern civilization, bounced back above $100 a barrel, as hopes of a swift resolution faded. Restricted traffic through the Strait, a chokepoint of vital importance, is causing predictable anxieties. Higher oil prices, naturally, stoke the fires of inflation – a beast that always demands to be fed.

The VIX index, a measure of market jitters and general apprehension, is hovering near levels not seen since the tariff wars of yesteryear. This suggests investors remain cautious, still attempting to gauge the long-term consequences of recent events. The S&P 500 has declined almost 5% in the last month – a gentle reminder that even the most carefully constructed financial castles are vulnerable to the winds of change.

Adding to the general unease, further troubles have emerged in the shadowy world of private credit. Ares Management, one of the larger establishments dealing in…alternative financing, has joined others in limiting withdrawals, signalling deeper distress within the sector. It seems even those who lend to the most secretive of enterprises are discovering that money, ultimately, isn’t infinite.3


1 The Grand Index, while sounding grand, is simply a weighted average of share prices. The weighting, of course, is determined by those with the most to gain from its fluctuations.
2 The Nasal Composite’s name is a historical quirk. It was originally intended to track companies involved in the production of nasal decongestants. Things…evolved.
3 Private credit, for the uninitiated, involves lending money to companies that prefer not to be scrutinized by the general public. This isn’t necessarily nefarious, but it does raise questions about transparency and risk.

Read More

2026-03-25 00:15